The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 20, 2018

Filed:

Mar. 17, 2014
Applicant:

Bayer Pharma Aktiengesellschaft, Berlin, DE;

Inventors:

Kai Thede, Berlin, DE;

William Scott, Guilford, CT (US);

Eckhard Bender, Langenfeld, DE;

Stefan Golz, Mülheim an der Ruhr, DE;

Andrea Hägebarth, Berlin, DE;

Philip Lienau, Berlin, DE;

Florian Puehler, Wellesley, MA (US);

Daniel Basting, Köln, DE;

Dirk Schneider, Wuppertal, DE;

Manfred Möwes, Berlin, DE;

Anja Richter, Berlin, DE;

Ludwig Zorn, Berlin, DE;

Ningshu Liu, Berlin, DE;

Ursula Mönning, Woltersdorf, DE;

Franziska Siegel, Berlin, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/5386 (2006.01); A61K 31/4439 (2006.01); A61K 31/496 (2006.01); A61K 31/433 (2006.01); A61K 31/4418 (2006.01); A61K 31/4995 (2006.01); A61K 31/551 (2006.01); A61K 31/553 (2006.01); A61K 45/06 (2006.01); C07C 205/45 (2006.01); C07C 233/54 (2006.01); C07C 233/15 (2006.01); C07C 205/59 (2006.01); C07C 317/44 (2006.01); C07C 229/64 (2006.01); C07C 255/56 (2006.01); C07D 213/75 (2006.01); C07D 295/15 (2006.01); C07D 213/82 (2006.01); C07D 333/38 (2006.01); C07D 285/135 (2006.01); C07D 295/155 (2006.01); C07D 213/76 (2006.01); C07D 213/73 (2006.01); C07D 277/56 (2006.01); C07D 231/14 (2006.01); C07D 401/12 (2006.01); C07D 417/12 (2006.01); C07D 263/34 (2006.01); C07D 487/08 (2006.01); C07D 271/06 (2006.01); C07D 271/07 (2006.01); C07D 271/113 (2006.01); C07D 207/34 (2006.01); C07D 498/08 (2006.01); C07D 277/46 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/433 (2013.01); A61K 31/4418 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/4995 (2013.01); A61K 31/5386 (2013.01); A61K 31/551 (2013.01); A61K 31/553 (2013.01); A61K 45/06 (2013.01); C07C 205/45 (2013.01); C07C 205/59 (2013.01); C07C 229/64 (2013.01); C07C 233/15 (2013.01); C07C 233/54 (2013.01); C07C 255/56 (2013.01); C07C 317/44 (2013.01); C07D 207/34 (2013.01); C07D 213/73 (2013.01); C07D 213/75 (2013.01); C07D 213/76 (2013.01); C07D 213/82 (2013.01); C07D 231/14 (2013.01); C07D 263/34 (2013.01); C07D 271/06 (2013.01); C07D 271/07 (2013.01); C07D 271/113 (2013.01); C07D 277/46 (2013.01); C07D 277/56 (2013.01); C07D 285/135 (2013.01); C07D 295/15 (2013.01); C07D 295/155 (2013.01); C07D 333/38 (2013.01); C07D 401/12 (2013.01); C07D 417/12 (2013.01); C07D 487/08 (2013.01); C07D 498/08 (2013.01);
Abstract

The present invention relates to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease such as cancer, wherein i.a.: Lrepresents an optionally substituted methylene or ethylene group; Lrepresents —N(H)—C(═O)— or —C(═O)—N(H)—; Rrepresents an optionally substituted 5- to 8-membered heterocycloalkyl, 4- to 10-membered heterocycloalkenyl, aryl, heteroaryl or —N(R7)(Ci-C6-alkyl) group; Rrepresents an optionally substituted 5- or 6-membered heteroaryl group; Rrepresents an optionally substituted phenyl group.


Find Patent Forward Citations

Loading…